Stromal fibronectin expression in patients with resected pancreatic ductal adenocarcinoma
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1477-7819
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
Stromal fibronectin expression in patients with resected pancreatic ductal adenocarcinoma ; volume:17 ; number:1 ; day:8 ; month:2 ; year:2019 ; pages:1-8 ; date:12.2019
World journal of surgical oncology ; 17, Heft 1 (8.2.2019), 1-8, 12.2019
- Urheber
-
Hu, Dingyuan
Ansari, Daniel
Zhou, Qimin
Sasor, Agata
Said Hilmersson, Katarzyna
Andersson, Roland
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1186/s12957-019-1574-z
- URN
-
urn:nbn:de:101:1-2019031017460107795353
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
- 14.08.2025, 10:49 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Hu, Dingyuan
- Ansari, Daniel
- Zhou, Qimin
- Sasor, Agata
- Said Hilmersson, Katarzyna
- Andersson, Roland
- SpringerLink (Online service)
Ähnliche Objekte (12)
A neoadjuvant therapy compatible prognostic staging for resected pancreatic ductal adenocarcinoma
Regulatory effects of SPARC on fibronectin mediated cellular responses of pancreatic ductal adenocarcinoma cells
Pancreatic ductal adenocarcinoma with inferior vena cava invasion: a report of three resected cases
Context-specific characterization of the stromal tumor microenvironment in pancreatic ductal adenocarcinoma
High‐grade mesenchymal pancreatic ductal adenocarcinoma drives stromal deactivation through CSF‐1
A PD-L2-based immune marker signature helps to predict survival in resected pancreatic ductal adenocarcinoma
Models of pancreatic ductal adenocarcinoma
Prognostic impact of circulating tumor DNA detection in portal and peripheral blood in resected pancreatic ductal adenocarcinoma patients
The role of S100A9 in the interaction between pancreatic ductal adenocarcinoma cells and stromal cells
Impact of tumor size on survival of patients with resected pancreatic ductal adenocarcinoma: a systematic review and meta-analysis
Programmed cell death ligand 1 cut-point is associated with reduced disease specific survival in resected pancreatic ductal adenocarcinoma
Distinct Indications for Adjuvant Therapy in Resected Invasive Mucinous Cystic Neoplasms of the Pancreas Compared with Pancreatic Ductal Adenocarcinoma
A neoadjuvant therapy compatible prognostic staging for resected pancreatic ductal adenocarcinoma
Regulatory effects of SPARC on fibronectin mediated cellular responses of pancreatic ductal adenocarcinoma cells
Pancreatic ductal adenocarcinoma with inferior vena cava invasion: a report of three resected cases
Context-specific characterization of the stromal tumor microenvironment in pancreatic ductal adenocarcinoma
High‐grade mesenchymal pancreatic ductal adenocarcinoma drives stromal deactivation through CSF‐1
A PD-L2-based immune marker signature helps to predict survival in resected pancreatic ductal adenocarcinoma
Models of pancreatic ductal adenocarcinoma
Prognostic impact of circulating tumor DNA detection in portal and peripheral blood in resected pancreatic ductal adenocarcinoma patients
The role of S100A9 in the interaction between pancreatic ductal adenocarcinoma cells and stromal cells
Impact of tumor size on survival of patients with resected pancreatic ductal adenocarcinoma: a systematic review and meta-analysis
Programmed cell death ligand 1 cut-point is associated with reduced disease specific survival in resected pancreatic ductal adenocarcinoma
Distinct Indications for Adjuvant Therapy in Resected Invasive Mucinous Cystic Neoplasms of the Pancreas Compared with Pancreatic Ductal Adenocarcinoma
A neoadjuvant therapy compatible prognostic staging for resected pancreatic ductal adenocarcinoma
Regulatory effects of SPARC on fibronectin mediated cellular responses of pancreatic ductal adenocarcinoma cells
Pancreatic ductal adenocarcinoma with inferior vena cava invasion: a report of three resected cases
Context-specific characterization of the stromal tumor microenvironment in pancreatic ductal adenocarcinoma
High‐grade mesenchymal pancreatic ductal adenocarcinoma drives stromal deactivation through CSF‐1
A PD-L2-based immune marker signature helps to predict survival in resected pancreatic ductal adenocarcinoma
Models of pancreatic ductal adenocarcinoma
Prognostic impact of circulating tumor DNA detection in portal and peripheral blood in resected pancreatic ductal adenocarcinoma patients
The role of S100A9 in the interaction between pancreatic ductal adenocarcinoma cells and stromal cells
Impact of tumor size on survival of patients with resected pancreatic ductal adenocarcinoma: a systematic review and meta-analysis
Programmed cell death ligand 1 cut-point is associated with reduced disease specific survival in resected pancreatic ductal adenocarcinoma